Enovix (NASDAQ:ENVX – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.01, Zacks reports. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. Enovix updated its Q1 2025 guidance to -0.210–0.150 EPS.
Enovix Price Performance
Shares of NASDAQ ENVX traded up $0.03 during midday trading on Wednesday, reaching $11.19. 10,623,974 shares of the company traded hands, compared to its average volume of 6,858,173. The stock’s 50-day simple moving average is $11.03 and its 200-day simple moving average is $10.29. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77. Enovix has a 12 month low of $5.70 and a 12 month high of $18.68. The firm has a market cap of $1.99 billion, a PE ratio of -6.95 and a beta of 1.87.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the stock. JPMorgan Chase & Co. cut their target price on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Benchmark reissued a “buy” rating and issued a $25.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. Janney Montgomery Scott downgraded shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective on the stock. in a research note on Thursday, October 31st. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $30.00 price target on shares of Enovix in a report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $20.50.
Insiders Place Their Bets
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total transaction of $729,750.00. Following the sale, the director now owns 99,497 shares of the company’s stock, valued at $968,105.81. This represents a 42.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 15.70% of the company’s stock.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
See Also
- Five stocks we like better than Enovix
- What is the MACD Indicator and How to Use it in Your Trading
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How to Plot Fibonacci Price Inflection Levels
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.